Sections:
Epithelial Ovarian Cancer Pathology and Inflammation Associated Molecular Targets
Is There a Role for Non-steroidal Anti-inflammatory Drugs (NSAIDS) in EOC Prevention?
Anti-inflammatory Phytochemicals
In conclusion, results from many published studies described above
indicate a definitive involvement of inflammation pathway in the
progression and treatment of ovarian cancer. Some anti-inflammatory
phytochemicals exhibit the activities to intervene the dysregulated
inflammation pathway, and may play a beneficial role in the treatment of
advanced EOC. However, there are many questions remain to be answered.
Further research in this area is urgently needed.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.